Equities

Blue Jet Healthcare Ltd

BLUEJET:NSI

Blue Jet Healthcare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)533.50
  • Today's Change4.50 / 0.85%
  • Shares traded167.11k
  • 1 Year change+38.57%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 09:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments3,2022,5491,814
Total Receivables, Net1,8782,4402,294
Total Inventory1,2981,2571,050
Prepaid expenses9.94158.47
Other current assets, total669389316
Total current assets7,0566,6505,483
Property, plant & equipment, net3,1881,8151,599
Goodwill, net------
Intangibles, net1.970.410
Long term investments199----
Note receivable - long term------
Other long term assets14315551
Total assets10,5888,6217,134
LIABILITIES
Accounts payable303538565
Accrued expenses843536
Notes payable/short-term debt000
Current portion long-term debt/capital leases271940
Other current liabilities, total1,6451,1471,104
Total current liabilities2,0601,7391,745
Total long term debt3.7915133
Total debt3134173
Deferred income tax32102.64
Minority interest------
Other liabilities, total414138
Total liabilities2,1361,8061,918
SHAREHOLDERS EQUITY
Common stock347347347
Additional paid-in capital--00
Retained earnings (accumulated deficit)8,1056,4684,868
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity8,4526,8155,215
Total liabilities & shareholders' equity10,5888,6217,134
Total common shares outstanding173173173
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.